A phase I dose-escalation trial of stereotactic body radiotherapy using 4 fractions for patients with localized prostate cancer

被引:0
|
作者
Takuro Kainuma
Shogo Kawakami
Hideyasu Tsumura
Takefumi Satoh
Ken-ichi Tabata
Masatsugu Iwamura
Kazushige Hayakawa
Hiromichi Ishiyama
机构
[1] Kitasato University School of Medicine,Department of Radiation Oncology
[2] Kitasato University School of Medicine,Department of Urology
来源
关键词
Prostate cancer; Stereotactic body radiotherapy; Dose-escalation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Update of the results of the Dutch Multicenter Dose Escalation Trial of radiotherapy for localized prostate cancer
    Al-Mamgani, A.
    van Putten, W.
    Heemsbergen, W.
    Hoogeman, M.
    Slot, A.
    Dielwart, M.
    Lebesque, J.
    Inerocci, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S81 - S81
  • [42] Dose escalation with stereotactic body radiotherapy for cervical cancer treatment
    Turna, Menekse
    Rzazade, Rashad
    Kucukmorkoc, Esra
    Kucuk, Nadir
    Canoglu, Mehmet Dogu
    Caglar, Hale Basak
    BMC CANCER, 2024, 24 (01)
  • [43] Helical tomotherapy - based dose escalation for localized prostate cancer - a multicentre phase I/II trial
    Winkler, C.
    Astner, S. T.
    Molls, M.
    Schill, S.
    Herfarth, K.
    Moser, L.
    Schwarz, R.
    Wittig, A.
    Geinitz, H.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 : 57 - 57
  • [44] Long-Term Benefits of Dose-Escalation in Localized Prostate Cancer
    Spratt, Daniel E.
    Michalski, Jeff M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (04): : 798 - 800
  • [45] A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma
    Correa, Rohann J. M.
    Ahmad, Belal
    Warner, Andrew
    Johnson, Craig
    MacKenzie, Mary J.
    Pautler, Stephen E.
    Bauman, Glenn S.
    Rodrigues, George B.
    Louie, Alexander V.
    RADIATION ONCOLOGY, 2018, 13
  • [46] A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma
    Rohann J. M. Correa
    Belal Ahmad
    Andrew Warner
    Craig Johnson
    Mary J. MacKenzie
    Stephen E. Pautler
    Glenn S. Bauman
    George B. Rodrigues
    Alexander V. Louie
    Radiation Oncology, 13
  • [47] Stereotactic Body Radiotherapy Using CyberKnife® for Localized Low- and Intermediate-risk Prostate Cancer: Initial Report on a Phase I/II Trial
    Nakamura, Ryosuke
    Hirata, Takero
    Suzuki, Osamu
    Otani, Keisuke
    Kai, Naoki
    Hatano, Koji
    Fujita, Kazutoshi
    Uemura, Motohide
    Imamura, Ryoichi
    Tanaka, Kazunori
    Yoshioka, Yasuo
    Nonomura, Norio
    Ogawa, Kazuhiko
    ANTICANCER RESEARCH, 2020, 40 (04) : 2053 - 2057
  • [48] DOSE-ESCALATION STUDY OF SINGLE-FRACTION STEREOTACTIC BODY RADIOTHERAPY FOR LIVER MALIGNANCIES
    Goodman, Karyn A.
    Wiegner, Ellen A.
    Maturen, Katherine E.
    Zhang, Zhigang
    Mo, Qianxing
    Yang, George
    Gibbs, Iris C.
    Fisher, George A.
    Koong, Albert C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (02): : 486 - 493
  • [49] Dose-escalation for early salvage radiotherapy in prostate cancer improves bDFS
    Latacz, E.
    Dirix, P.
    De laere, B.
    Van Dam, P.
    Meijnders, P.
    Huget, P.
    Verellen, D.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S859 - S860
  • [50] A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases
    Meyer, Jeffrey J.
    Foster, Ryan D.
    Lev-Cohain, Naama
    Yokoo, Takeshi
    Dong, Ying
    Schwarz, Roderich E.
    Rule, William
    Tian, Jing
    Xie, Yang
    Hannan, Raquibul
    Nedzi, Lucien
    Solberg, Timothy
    Timmerman, Robert
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (01) : 218 - 224